GB0516464D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0516464D0
GB0516464D0 GB0516464A GB0516464A GB0516464D0 GB 0516464 D0 GB0516464 D0 GB 0516464D0 GB 0516464 A GB0516464 A GB 0516464A GB 0516464 A GB0516464 A GB 0516464A GB 0516464 D0 GB0516464 D0 GB 0516464D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0516464A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to GB0516464A priority Critical patent/GB0516464D0/en
Publication of GB0516464D0 publication Critical patent/GB0516464D0/en
Priority to AU2006278216A priority patent/AU2006278216A1/en
Priority to MX2008001929A priority patent/MX2008001929A/en
Priority to PCT/EP2006/007869 priority patent/WO2007017262A1/en
Priority to DK06763016.0T priority patent/DK1912991T3/en
Priority to EP10172674A priority patent/EP2272848B1/en
Priority to BRPI0614270-2A priority patent/BRPI0614270A2/en
Priority to PL06763016T priority patent/PL1912991T3/en
Priority to CA002618963A priority patent/CA2618963A1/en
Priority to PT06763016T priority patent/PT1912991E/en
Priority to UAA200801702A priority patent/UA95780C2/en
Priority to NZ565494A priority patent/NZ565494A/en
Priority to JP2008525475A priority patent/JP2009504592A/en
Priority to KR1020087005717A priority patent/KR20080034993A/en
Priority to CA002626723A priority patent/CA2626723A1/en
Priority to TW095128952A priority patent/TW200800217A/en
Priority to BRPI0615145-0A priority patent/BRPI0615145A2/en
Priority to US12/063,434 priority patent/US8143264B2/en
Priority to ES10172674T priority patent/ES2401128T3/en
Priority to AT06763016T priority patent/ATE487719T1/en
Priority to EA200800564A priority patent/EA200800564A1/en
Priority to DE602006018151T priority patent/DE602006018151D1/en
Priority to ARP060103459A priority patent/AR055369A1/en
Priority to PE2010000241A priority patent/PE20100486A1/en
Priority to PCT/EP2006/007865 priority patent/WO2007017261A1/en
Priority to JP2008525474A priority patent/JP5112316B2/en
Priority to CNA2006800374272A priority patent/CN101282976A/en
Priority to SI200630916T priority patent/SI1912991T1/en
Priority to PE2006000963A priority patent/PE20070405A1/en
Priority to EP06776699A priority patent/EP1912992A1/en
Priority to US12/063,432 priority patent/US20100179128A1/en
Priority to EA200800555A priority patent/EA014556B1/en
Priority to CN2006800374709A priority patent/CN101282977B/en
Priority to AU2006278215A priority patent/AU2006278215A1/en
Priority to MYPI20063833A priority patent/MY142067A/en
Priority to EP06763016A priority patent/EP1912991B1/en
Priority to MX2008001931A priority patent/MX2008001931A/en
Priority to KR1020087005724A priority patent/KR20080038396A/en
Priority to ZA200800778A priority patent/ZA200800778B/en
Priority to IL189081A priority patent/IL189081A0/en
Priority to IL189083A priority patent/IL189083A0/en
Priority to MA30628A priority patent/MA29692B1/en
Priority to MA30629A priority patent/MA29693B1/en
Priority to CR9748A priority patent/CR9748A/en
Priority to CR9749A priority patent/CR9749A/en
Priority to NO20081212A priority patent/NO20081212L/en
Priority to NO20081211A priority patent/NO20081211L/en
Priority to HK08107505.5A priority patent/HK1116779A1/en
Priority to HR20100725T priority patent/HRP20100725T1/en
Priority to CY20111100033T priority patent/CY1111757T1/en
Priority to US13/088,962 priority patent/US20110257205A1/en
Ceased legal-status Critical Current

Links

GB0516464A 2005-08-10 2005-08-10 Novel compounds Ceased GB0516464D0 (en)

Priority Applications (51)

Application Number Priority Date Filing Date Title
GB0516464A GB0516464D0 (en) 2005-08-10 2005-08-10 Novel compounds
AU2006278216A AU2006278216A1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective HM74A agonists
MX2008001929A MX2008001929A (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists.
PCT/EP2006/007869 WO2007017262A1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
DK06763016.0T DK1912991T3 (en) 2005-08-10 2006-08-08 Xanthine Derivatives as Selective HM74A Agonists
EP10172674A EP2272848B1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective HM74A agonists
BRPI0614270-2A BRPI0614270A2 (en) 2005-08-10 2006-08-08 xanthine derivatives as selective ha74a agonists
PL06763016T PL1912991T3 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
CA002618963A CA2618963A1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
PT06763016T PT1912991E (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
UAA200801702A UA95780C2 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
NZ565494A NZ565494A (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective HM74A agonists
JP2008525475A JP2009504592A (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective HM74A agonists
KR1020087005717A KR20080034993A (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
CA002626723A CA2626723A1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
TW095128952A TW200800217A (en) 2005-08-10 2006-08-08 Novel compounds
BRPI0615145-0A BRPI0615145A2 (en) 2005-08-10 2006-08-08 xanthine derivatives as selective hm74a agonists
US12/063,434 US8143264B2 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective HM74A agonists
ES10172674T ES2401128T3 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective agonists of HM74A
AT06763016T ATE487719T1 (en) 2005-08-10 2006-08-08 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS
EA200800564A EA200800564A1 (en) 2005-08-10 2006-08-08 DERIVATIVES OF XANTHINE AS SELECTIVE AGONISTS NM74A
DE602006018151T DE602006018151D1 (en) 2005-08-10 2006-08-08 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS
ARP060103459A AR055369A1 (en) 2005-08-10 2006-08-08 COMPOUNDS DERIVED FROM XANTINA, ITS USE TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF A DISEASE MEDIATED BY THE RECEIVER HM74A, FORMULATIONS AND PHARMACEUTICAL COMBINATION THAT INCLUDE IT AND METHOD OF PREPARATION OF THE SAME
PE2010000241A PE20100486A1 (en) 2005-08-10 2006-08-08 XANTHINE-DERIVED COMPOUNDS AS AGONISTS OF THE NICOTINIC ACID RECEPTOR HM74A
PCT/EP2006/007865 WO2007017261A1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
JP2008525474A JP5112316B2 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective HM74A agonists
CNA2006800374272A CN101282976A (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective HM74A agonists
SI200630916T SI1912991T1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
PE2006000963A PE20070405A1 (en) 2005-08-10 2006-08-08 XANTHINE-DERIVED COMPOUNDS AS AGONISTS OF THE NICOTINIC ACID RECEPTOR HM74A
EP06776699A EP1912992A1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
US12/063,432 US20100179128A1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
EA200800555A EA014556B1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
CN2006800374709A CN101282977B (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
AU2006278215A AU2006278215A1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective HM74A agonists
MYPI20063833A MY142067A (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists, processes for the manufacture of said derivatives, formulations comprising these derivatives, and their use in the treatment of diseases where under-activation of the hm74a receptor contributes to the disease
EP06763016A EP1912991B1 (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
MX2008001931A MX2008001931A (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists.
KR1020087005724A KR20080038396A (en) 2005-08-10 2006-08-08 Xanthine derivatives as selective hm74a agonists
ZA200800778A ZA200800778B (en) 2005-08-10 2008-01-25 Xanthine derivatives as selective HM74A agonists
IL189081A IL189081A0 (en) 2005-08-10 2008-01-28 Xanthine derivatives as selective hm74a agonists
IL189083A IL189083A0 (en) 2005-08-10 2008-01-28 Xanthine derivatives as selective hm74a agonists
MA30628A MA29692B1 (en) 2005-08-10 2008-02-08 XANTHINE DERIVATIVES AS SELECTIVE AGONISTS OF HM74A
MA30629A MA29693B1 (en) 2005-08-10 2008-02-08 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS
CR9748A CR9748A (en) 2005-08-10 2008-02-21 DERIVATIVES OF XANTINA AS SELECTIVE AGONISTS OF HM74A
CR9749A CR9749A (en) 2005-08-10 2008-02-21 XANTINA DERIVATIVES AS SELECTIVE HM74A AGONISTS
NO20081212A NO20081212L (en) 2005-08-10 2008-03-07 Xanthine derivatives as selective HM74A agonists
NO20081211A NO20081211L (en) 2005-08-10 2008-03-07 Xanthine derivatives as selective HM74A agonists
HK08107505.5A HK1116779A1 (en) 2005-08-10 2008-07-08 Xanthine derivatives as selective hm74a agonists
HR20100725T HRP20100725T1 (en) 2005-08-10 2010-12-27 Xanthine derivatives as selective hm74a agonists
CY20111100033T CY1111757T1 (en) 2005-08-10 2011-01-12 XANTHINI PRODUCTS AS ELECTRIC SUSPENSIONS HM74A
US13/088,962 US20110257205A1 (en) 2005-08-10 2011-04-18 Xanthine derivatives as selective hm74a agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0516464A GB0516464D0 (en) 2005-08-10 2005-08-10 Novel compounds

Publications (1)

Publication Number Publication Date
GB0516464D0 true GB0516464D0 (en) 2005-09-14

Family

ID=34984414

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0516464A Ceased GB0516464D0 (en) 2005-08-10 2005-08-10 Novel compounds

Country Status (4)

Country Link
CN (2) CN101282976A (en)
GB (1) GB0516464D0 (en)
UA (1) UA95780C2 (en)
ZA (1) ZA200800778B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0922134A2 (en) * 2008-12-08 2015-08-18 Glaxosmithkline Llc Compounds
NZ605690A (en) * 2010-08-16 2014-06-27 Boehringer Ingelheim Int Oxadiazole inhibitors of leukotriene production
CN102276610B (en) * 2011-05-04 2013-01-09 北京工业大学 Method for preparing N7-guanine alkylate
JP7178357B2 (en) * 2017-03-07 2022-11-25 エフ．ホフマン－ラ ロシュ アーゲー Oxadiazole transient receptor potential channel inhibitor
JP2022549807A (en) * 2019-09-25 2022-11-29 ゴールドフィンチ バイオ，インク． Xanthine CB1 inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE388951T1 (en) * 2001-07-03 2008-03-15 Novo Nordisk As DPP-IV INHIBITING PURINE DERIVATIVES FOR THE TREATMENT OF DIABETES
GB0319124D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds

Also Published As

Publication number Publication date
CN101282977A (en) 2008-10-08
CN101282977B (en) 2011-07-27
CN101282976A (en) 2008-10-08
ZA200800778B (en) 2008-11-26
UA95780C2 (en) 2011-09-12

Similar Documents

Publication Publication Date Title
AP2007004171A0 (en) Novel compounds
EP1868611A4 (en) Novel compounds
EP1868612A4 (en) Novel compounds
GB0503955D0 (en) Novel compounds
GB0516464D0 (en) Novel compounds
EP1869026A4 (en) Novel compounds
GB0500140D0 (en) Novel compounds
GB0500285D0 (en) Novel compounds
GB0500839D0 (en) Novel polyacetylen compounds
GB0503129D0 (en) Novel compounds
GB0503127D0 (en) Novel compounds
GB0503132D0 (en) Novel compounds
GB0500920D0 (en) Novel compounds
GB0503126D0 (en) Novel compounds
GB0503133D0 (en) Novel compounds
GB0503134D0 (en) Novel compounds
GB0503123D0 (en) Novel compounds
GB0503131D0 (en) Novel compounds
GB0500919D0 (en) Novel compounds
GB0500916D0 (en) Novel compounds
GB0503122D0 (en) Novel compounds
GB0503121D0 (en) Novel compounds
GB0500887D0 (en) Novel compounds
GB0500923D0 (en) Novel compounds
GB0501962D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)